Trials that matter: Rosiglitazone, ramipril, and the prevention of type 2 diabetes

被引：10
|
作者：
Nathan, David M. [1 ]
Berkwits, Michael [1 ]
机构：
[1] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2007年 / 146卷 / 06期
关键词：
D O I：
10.7326/0003-4819-146-6-200703200-00015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：461 / 463
页数：3
相关论文
共 50 条
  • [1] Rosiglitazone, but not ramipril, prevents onset of type 2 diabetes in high-risk patients
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (1): : 6 - 6
  • [2] Impact of ramipril and rosiglitazone on incidence of diabetes. DREAM study (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication)
    Standl, E.
    Nitschmann, S.
    INTERNIST, 2007, 48 (10): : 1173 - +
  • [3] Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
    Holman, Rury R.
    Zinman, Bernie
    Yusuf, Salim
    Sheridan, Patrick M.
    Anand, Sonia S.
    Bosch, Jackie J.
    Conget, Ignacio
    Davies, Melanie J.
    Pirags, Valdis
    Dagenais, Gilles R.
    Pogue, Janice M.
    Zimmet, Paul Z.
    Gerstein, Hertzel C.
    DIABETES CARE, 2011, 34 (06) : 1265 - 1269
  • [4] Lifestyles matter in the prevention of type 2 diabetes
    Uusitupa, M
    DIABETES CARE, 2002, 25 (09) : 1650 - 1651
  • [5] Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?
    Rahman, Sayeeda
    Ismail, Aziz Al-Shafi
    Ismail, Shaiful Bhari
    Naing, Nyi Nyi
    Rahman, Abdul Rashid Abdul
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2010, 2 : 83 - 87
  • [6] Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
    Boyko, E. J.
    Gerstein, H. C.
    Mohan, V.
    Yusuf, S.
    Sheridan, P.
    Anand, S.
    Shaw, J. E.
    DIABETIC MEDICINE, 2010, 27 (11) : 1226 - 1232
  • [7] Beeinflussung der Diabetesinzidenz durch Ramipril und RosiglitazonDREAM-Studie (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication)Influence of diabetes incidence by ramipril and rosiglitazoneDREAM study (Diabetes reduction assessment with ramipril and rosiglitazone medication)
    E. Standl
    S. Nitschmann
    Der Internist, 2007, 48 (10): : 1173 - 1176
  • [8] The DREAM trial: Using ramipril and rosiglitazone to prevent diabetes
    Viral Shah
    Richard E. Pratley
    Current Diabetes Reports, 2007, 7 (1) : 53 - 55
  • [9] Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
    Hadi, Muhammad Abdul
    ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (01) : 2 - 2
  • [10] PREVENTING TYPE 2 DIABETES Is there a need for new diabetes prevention trials?
    Faerch, Kristine
    Vistisen, Dorte
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
12345